Veradigm has been granted a patent for a system that secures prescription data on a computer network. The technology includes a prescription module and an authentication module that manage user authentication, disable entry fields temporarily, and utilize a soft token for secure data registration. GlobalData’s report on Veradigm gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Veradigm, was a key innovation area identified from patents. Veradigm's grant share as of July 2024 was 78%. Grant share is based on the ratio of number of grants to total number of patents.
Securing prescription data on a computer network
The patent US12046339B1 describes an innovative apparatus and method for processing and securing prescription data within a computer network. Central to this invention is a processor that operates in conjunction with a memory, a communications interface, a prescription module, and an authentication module. The prescription module is designed to activate a prescription application for registering prescription data only after user authentication. A key feature of the authentication module is its ability to automatically disable an entry field in the prescription application for a predetermined period following user authentication. During this time, the module ensures that the application remains active and transmits a one-time password (OTP) to an external device. Once the OTP is sent, the entry field is reactivated, allowing the user to input the OTP for secondary authentication of the prescription data.
Additionally, the patent outlines various functionalities of the authentication module, including the ability to monitor the status of the prescription application—whether it is closed, minimized, or running in the background. If the application is not active, the module can extend the disabling of the entry field for another predetermined period. The authenticated prescription data can then be transmitted to a pharmacy computer system, where it may undergo further authentication by an associated service server. Notably, the patent also encompasses the handling of prescription data related to controlled substances, emphasizing the importance of security and verification in the management of sensitive medical information.
To know more about GlobalData’s detailed insights on Veradigm, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
